Drug intelligence / Profile preview

Omapplusone

Development stage
Unknown
Lead developer
HK inno.N Corporation
Modality
Small Molecules
Administration
Intravenous
01

Overview

Omapplusone is a total parenteral nutrition (TPN) product developed by HK inno.N. It is a three-chamber bag (3CB) system designed to provide essential nutrients to patients who cannot receive adequate nutrition through oral or enteral routes. The formulation is an upgraded version of the company's Omap product, containing a lipid emulsion (a blend of soybean oil, medium-chain triglycerides, olive oil, and fish oil rich in omega-3 fatty acids), amino acids, glucose, and electrolytes. The plusone designation signifies the addition of zinc (as zinc gluconate) to the formulation, addressing the common clinical need for trace element supplementation in patients receiving long-term parenteral nutrition. It is available in formulations for both central (Omapplusone Inj) and peripheral (Omapplusone Peri Inj) venous administration.

Brand names
OmapplusoneOmapplusone Peri
Other names
Omap Plus OneOmapplusone InjOmapplusone Peri Inj

Beyond the preview

Go deeper on Omapplusone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omapplusone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call